Cochrane Abstracts
Use of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Use of Reflective Materials During Phototherapy for Newborn Infants With Unconjugated Hyperbilirubinaemia." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434529/all/Use_of_reflective_materials_during_phototherapy_for_newborn_infants_with_unconjugated_hyperbilirubinaemia.
Use of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemia. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434529/all/Use_of_reflective_materials_during_phototherapy_for_newborn_infants_with_unconjugated_hyperbilirubinaemia. Accessed February 19, 2025.
Use of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemia. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434529/all/Use_of_reflective_materials_during_phototherapy_for_newborn_infants_with_unconjugated_hyperbilirubinaemia
Use of Reflective Materials During Phototherapy for Newborn Infants With Unconjugated Hyperbilirubinaemia [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434529/all/Use_of_reflective_materials_during_phototherapy_for_newborn_infants_with_unconjugated_hyperbilirubinaemia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Use of reflective materials during phototherapy for newborn infants with unconjugated hyperbilirubinaemia
ID - 434529
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434529/all/Use_of_reflective_materials_during_phototherapy_for_newborn_infants_with_unconjugated_hyperbilirubinaemia
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
